Conversation with CND Life Sciences

Special Bonus Episode: Conversation with CND Life Sciences

 

In this special bonus episode, BGF Executive Director Katrina Kahl talks with CND Life Science's Chief Medical Officer and Co-Founder Todd Levine, MD about the benefits of the company's evidence-based test to help diagnose synucleinopathies, which includes Parkinson's disease.

 

More about Dr. Levine:

Dr. Todd Levine is one of the three founders of CND Life Sciences and serves as its Chief Medical Officer, playing a key role in the delivery of diagnostic services and ongoing technology development. Dr. Levine also serves as the Director of Neuroscience Research at HonorHealth Research Institute and has over 25 years of experience as a clinical neurologist with a sub-specialty in disorders of the peripheral nervous system. In 2010, he founded his first medical diagnostics company called Corinthian Reference Lab (CRL). Based in Fort Worth, Texas, CRL has processed over 50,000 skin biopsies, receiving specimens from over 4,000 different neurologists across the US and Canada. He received his medical degree from Duke University and did his residency and fellowship at Washington University in St Louis. He has served as the Chairman of the Neuromuscular Division of the American Academy of Neurology and has served as the Medical Director of Neurology for HonorHealth in Phoenix, Arizona.

 

https://cndlifesciences.com/syn-one-test/